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"Determination" implies that although a given cell displays none of the rec- 
ognizable phenotypic traits characteristic of a particular pathway of differenti- 
ation it may nonetheless be committed to that pathway; the cell's future genetic 
program is already decided,  though not yet implemented. Implementation of 
this program ("differentiation") may normally involve the interaction of a spe- 
cific molecule with a  specific  receptor on the determined cell, but alternately 
other agents interacting with the cell, or functioning generally as mediators of 
phenotypic expression, may initiate the process.  An example of the  latter  is 
cyclic AMP (cAMP). 
To understand the function of the thymus it is necessary to know whether 
this  organ is  responsible  for  genetic  determination of the  T  lymphocyte or 
whether it only supplies the signal for differentiation. Among other considera- 
tions,  this may decide whether restoration of immune function to  thymus- 
deprived subjects, in the sense of providing them with functional T cells, requires 
that they be supplied with thymus itself or any product of the thymus. 
Here we summarize evidence from our own work showing that it is differentia- 
tion and not genetic determination of T cells for which the thymus is responsi- 
ble, a conclusion that is implicit in previous studies (1-3). 
When precursor cells from spleen or bone marrow of normal or nu/nu thymus- 
less mice, or from embryonic liver, are incubated with a product of mouse thy- 
mus, they differentiate into T cells, defined as cells expressing the antigens TL, 
Thy-1,  Gix, Ly-1, Ly-2/Ly-3, and  Ly-5  (4,5;  and  subsequent  unpublished 
data). 
Table I shows that agents of nonthymic origin can induce T-cell differentia- 
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TABLE  I 
Summary of Experiments  Showing Generation of T Cells from Precursor Cells under the 
Influence of Thymic and Nonthymlc Agents 
Material tested for inducer activity  Criterion of T cell induction 
Source 
Mouse thymus 
Mouse spleen 
Description* 
Expression of TL or 
Thy-1 antigen 
Fr. 2 (KK) 
Fr. 2 (KK) 
Medium 
II: in 
I: in vitro~  nu/nu 
mice§ 
Induced cells 
% 
20 
<10 
20,40 
Mouse thymus 
Calf thymus 
Calf thymus 
Calf thymus 
Calf thymus 
Calf spleen 
Calf muscle 
Rat thymus 
Chicken thymus 
Human thymus 
Fr. 3 
Fr. 2 
Ft. 3 
5 
6 
Ft. 3 
Fr. 3 
Ft. 2 
Fr. 2 
Ft. 3 
20-23 
<10 
<10 
m 
Calf thymus¶ 
(AG)  40-45 
(KK)  20-25 
(AG)  40-45 
(AG)  25-30 
(AG)  18-22 
(AG)  40-45 
(AG)  40-45 
(KK)  20-25 
(KK)  25-30 
(AG)  25-30 
20 
25 
20-25 
15-19 
< 10, < l0 
25 
10 
30 
<10 
Appearance of helper 
effect in vitroll 
cAMP 
DB-cAMP 
Poly A:U 
Endotoxin 
BSA, Medium 
Ft. 2 (KK) + 
Aminophylline 
Fr. 2  (KK)  + 
Insulin 
Fr. 2  (KK) + 
Medium 
PFC/culture 
5th 
exp. 
24 
~10 
Because of space limitations, details of materials and methods can be indicated for  the 
most part only by key references to where full descriptions can be found. 
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tion  from  precursor  cells  in  vitro,  and  that  the  induced  T  cells  may  acquire 
functional (helper) activity as well as T-cell antigens, regardless of whether dif- 
ferentiation was initiated by a  thymic or a  nonthymic  product poly  (A:U). 
To determine further whether intracellular cAMP may be implicated in T-cell 
et al.  (6)  with minor modification  (4).  (AG)  =  fraction sent by Dr.  A. L.  Goldstein for 
testing at Sloan-Kettering Center.  Fractions numbered according to their degree of purifi- 
cation  (6).  cAMP  =  adenosine  3',5'-cyclic  monophosphoric acid  (Sigma  Chemical  Co., 
St. Louis, Mo.) 1 mM. DB-cAMP =  Ns, O2-dibuturyl-adenosine 3 r, 5r-cyclic monophosphoric 
acid (Sigma)  1 mM (also active at 0.1 mM). Poly  A:U  =  polyadeuylic-uridylic acid  (pro- 
vided by Dr. F. Lacour, Paris; sample SK 30-18413) tested in five serial log 10 dilutions from 
1 to 0.0001/zg/ml; induction activity in vitro optimal between 0.1 and 0.001/zg/ml; inactive 
at higher concentrations. Endotoxin  =  Escherichia coli lipopolysaccharide  (LPS)  (Bayer, 
Germany)  20 /zg/ml.  BSA  =  bovine serum albumin  (Path-o-cyte-5,  lot  20,  Pentex Bio- 
chemical, Kankakee, Ill.) 5%. Aminophylline =  [(theophylline)  ~. ethylenediamine •  2H20] crys- 
talline (Sigma)  1  mM.  Insulin  =  40 U  regular  Iletin  (Eli  Lilly  and  Co.,  Indianapolis, 
Ind.) 80 mU/ml. 
:~ Figures in this column represent percent of starting cell population induced to express 
TL and Thy-1 antigens in vitro (for details see Komuro and Boyse, reference 4). The starting 
population was the "B" layer of mouse spleen cells fractionated on BSA density gradients 
as before  (4)  but at the interface 20-23% with the source of BSA (lot 20,  Pentex) now in 
use.  This fraction contains virtually no T  (Thy-1  +)  cells; TL  +  T  cells are  normally con- 
fined exclusively to the thymus. The percent  cells  induced  is  calculated  from  the  results 
of  the  cytotoxicity  test  with  TL  or  Thy-1 antiserum according to the formula  100  X 
(a  --  b)/a;  a  =  viable cells percent (no fraction or agent included); b  =  viable cells per- 
cent fraction or agent included)  (4).  Results  for TL and Thy-1 antigens were  always  con- 
cordant. A figure of 10  or higher is taken as  significant, although with present  standard- 
ization of  technique a  negative  control  reading higher than 5  is exceptional. 
The only inducer-positive tissue so far identified in the mouse is thymus  (4).  Previous 
and present negative results with mouse spleen Fr.  2  (KK),  contrasting with the positive 
results reported here for calf spleen Fr. 3  (AG), can have numerous explanations based on 
differences in preparation and concentration, but the salient point is that Fr. 3 from a  tissue 
other than thymus can have inducer activity; thus the activity of Fr.  3  of thymus is not 
necessarily attributable to  a  specific thymic factor.  Fetal  bovine serum has shown occa- 
sional low inducer activity at a  concentration of 5%, as J.  F.  Bach has observed with the 
rosette  test  (personal  communication).  A  positive  result  was  obtained  with  DB-cAMP; 
also cAMP was active, but with a  higher minimal inductive dose, which accords with re- 
ports that although the permeability of most cell membranes to cAMP is small, some cells 
do admit cAMP to at least some extent (reviewed in reference 7). 
§ Thymus-less nu/nu mice were injected intraperitoneally with mouse thymus Fr. 2 (KK) 
or mouse spleen Ft. 2  (KK)  1.0 ml daily for 6 days; or with calf thymus Ft. 2  (KK) 0.5 ml 
daily for 3 wk; or with poly A:U 500/zg once; and their lymph node cells tested for Thy-1 
(0) expression 3 days later. 
11 Induction  of  the helper property  was assayed  according  to  the culture  technique of 
Mishell and Dutton  (8)  and expressed as plaque-forming cells (PFC)  per culture on day 4 
(exps. 1-4) or day 3 (exp.  5). Either (a) the fraction or agent to be tested was added directly 
to  cultures of unfractionated nu/nu  spleen cells,  or  (b)  unfractionated nu/nu  spleen cells 
processed for induction of TL  and Thy-1 antigens as described for column I  of this table 
were washed and then cultured. 
¶ In this single experiment with aminophylline and insulin the level of induction by Fr. 2 
(KK) alone (control) was unusually low  (10%); we regard this experiment as no more than 
a favorable indication as to how the mechanism of induction may be better defined (see text). 1030  SCHEID  ET  AL.  BRIEF  DEFINITIVE  REPORT 
differentiation, aminophylline, an inhibitor of phosphodiesterases (9), and in- 
sulin, reported to be an inhibitor of adenylate cyclase (10), were tested for their 
ability to enhance and inhibit induction, respectively. A single experiment tend- 
ing in that direction is shown in Table I, suggesting possibly that thymosin may 
function via adenylate cyclase and that cAMP production may play an essen- 
tial intracellular role in signalling the determined procursor cell to differentiate. 
In the same context, we note that poly A: U is reported to raise adenylate cy- 
clase activity in mouse spleen (11). 
COMMENT 
(a) The T-cell precursor, found in spleen and bone marrow of nu/nu mice (5) 
as well as of normal mice (4), and in embryonic liver (5), is already determined, 
i.e.,  is  already genetically programmed for the T-lymphocyte differentiation 
pathway, although as yet it has none of the known phenotypic traits that dis- 
tinguish the T  lymphocyte. The thymus is not concerned in this, but supplies 
the starting signal  for differentiation. This being so,  a  number of agents,  of 
which cAMP has  the  clearest rationale,  can substitute  for the physiological 
thymic inducer (and see reference 12). 
(b) There is no compelling reason at present to postulate any effector func- 
tion for the thymus other than to issue a signal for differentiation, for a pre- 
cursor cell induced to differentiate into a cell bearing the T-cell surface compo- 
nents (antigens specified by genes in linkage groups II, IX, XI, XII, and others) 
also becomes competent to cooperate with B cells in the production of antibody 
to sheep red blood cells (SRBC) in vitro (Table I  and reference 3). 
(c) Agents such as poly A: U that appear to substitute for T  cells in coopera- 
tive tests with B  cells are in reality more probably inducing differentiation of 
T  cells from precursor cells present in the T  cell-depleted populations used to 
supply B  cells.  Restoration of immune faculties to thymectomized irradiated 
mice by such an agent (13)  presumably has the same basis, i.e., induction of 
T  cells from precursor cells (note the induction of Thy-1  + cells in nu/nu mice 
given poly A: U, Table I). Before classifying any antigen as "T-cell independ- 
ent" it is necessary to know whether it has the property of inducing T-cell dif- 
ferentiation. 
(d) It will be essential to establish what correlations there may be among the 
three assays for T-cell induction, which depend on the criteria: (i) presence of 
T-cell antigens, (ii) rosette formation, and (iii) helper function. An important 
distinction is that the first of these tests measures the total number of T  cells 
induced, whereas the latter two tests measure only the small fraction of cells 
acquiring the capacity to react specifically with SRBC. Complete correlation of 
the three assays can be expected only if the proportion of SRBC-reactive T cells 
induced is constant under all conditions. On such grounds explanations can be 
sought for the apparent discrepancy that rosette-forming cells decline in num- 
bers more rapidly after adult thymectomy (14) than do Thy-1  + cells (and more 
rapidly than the overall immunocompetence of the thymectomized mouse). SCHEID  ET  AL.  BRIEF  DEFINITIVE  REPORT  1031 
(e) Accepting that T-cell differentiation can be induced both specifically by 
thymosin, an exclusively thymic factor, and also nonspecifically by other agents, 
how can thymosin best be distinguished from these other agents in an assay in 
vitro? One possibility, supported by a few encouraging tests we have made, is 
to develop a similar assay for induction of B cells from B-cell precursors. The 
two assays side-by-side would exclude agents capable of inducing both types of 
precursors to differentiate. Further scrutiny could then be limited to agents or 
fractions with the specific capacity to induce differentiation of T-cell precursors 
exclusively. 
(f) The fact that T-cell differentiation can be initiated  by cAMP and poly 
A: U suggests ways of ascertaining whether agents that are not exclusive prod- 
ucts of thymus can induce  a  full  range of antigen receptors on T  cells,  and 
whether normal immunocompetence can be fully restored to thymus-deprived 
animals by such agents. This might bear on whether the thymus plays a part 
in generating diversity of antigen receptors on T  cells, or has any sentinel role 
in limiting the range of T-cell antigen receptors to those that are physiologically 
permissible.  But whether initiation  of T-cell differentiation,  indicated by the 
appearance of T-cell antigens in the in vitro assay, inevitably entails irreversi- 
ble complete maturation of the precursor cell regardless of whether the inducer 
is thymosin or some other agent has yet to be decided. 
We thank Doctors John W. Hadden, Gary W. Litman, and Martin Sonenberg for critical 
readings of the manuscript. 
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